Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Shapiro

Showing results (831-840 of 1,171) with videos related to

Pageof 118
Sort By:
Scientific Reports|March 17, 2017
pNaKtide Attenuates Steatohepatitis and Atherosclerosis by Blocking Na/K-ATPase/ROS Amplification in C57Bl6 and ApoE Knockout Mice Fed a Western DietKomal Sodhi, Krithika Srikanthan, Perrine Goguet-Rubio, et al.
Oncogene|February 2, 1999
Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motilityR Salgia, J L Li, D S Ewaniuk, et al.
Intensive Care Medicine Experimental|April 16, 2023
Effect of intravenous fluid volume on biomarkers of endothelial glycocalyx shedding and inflammation during initial resuscitation of sepsisStephen Macdonald, Erika Bosio, Gerben Keijzers, et al.
BMC Genomics|December 17, 2009
Transcriptional profiling of trait deterioration in the insect pathogenic nematode Heterorhabditis bacteriophoraBishwo N Adhikari, Chin-Yo Lin, Xiaodong Bai, et al.
Targeted Oncology|December 2, 2022
Phase I Study Evaluating Glesatinib (MGCD265), An Inhibitor of MET and AXL, in Patients with Non-small Cell Lung Cancer and Other Advanced Solid TumorsChristian Kollmannsberger, Herbert Hurwitz, Lyudmila Bazhenova, et al.
Resuscitation|November 20, 2018
Partial pressure of arterial carbon dioxide after resuscitation from cardiac arrest and neurological outcome: A prospective multi-center protocol-directed cohort studyJ Hope Kilgannon, Benton R Hunter, Michael A Puskarich, et al.
Clinical Pharmacology in Drug Development|January 13, 2021
Pharmacokinetics and Safety of PTC596, a Novel Tubulin-Binding Agent, in Subjects With Advanced Solid TumorsGeoffrey I Shapiro, Edward O'Mara, Oscar L Laskin, et al.
Oncogene|April 15, 2008
BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer modelsD Li, L Ambrogio, T Shimamura, et al.
Lung Cancer (Amsterdam, Netherlands)|December 11, 2021
A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancerRuth Plummer, Emma Dean, Hendrik-Tobias Arkenau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2010
A phase I study of foretinib, a multi-targeted inhibitor of c-Met and vascular endothelial growth factor receptor 2Joseph Paul Eder, Geoffrey I Shapiro, Leonard J Appleman, et al.
Pageof 118

Showing results (831-840 of 1,171) with videos related to

Sort By:
Pageof 118
Scientific Reports|March 17, 2017
pNaKtide Attenuates Steatohepatitis and Atherosclerosis by Blocking Na/K-ATPase/ROS Amplification in C57Bl6 and ApoE Knockout Mice Fed a Western DietKomal Sodhi, Krithika Srikanthan, Perrine Goguet-Rubio, et al.
Oncogene|February 2, 1999
Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motilityR Salgia, J L Li, D S Ewaniuk, et al.
Intensive Care Medicine Experimental|April 16, 2023
Effect of intravenous fluid volume on biomarkers of endothelial glycocalyx shedding and inflammation during initial resuscitation of sepsisStephen Macdonald, Erika Bosio, Gerben Keijzers, et al.
BMC Genomics|December 17, 2009
Transcriptional profiling of trait deterioration in the insect pathogenic nematode Heterorhabditis bacteriophoraBishwo N Adhikari, Chin-Yo Lin, Xiaodong Bai, et al.
Targeted Oncology|December 2, 2022
Phase I Study Evaluating Glesatinib (MGCD265), An Inhibitor of MET and AXL, in Patients with Non-small Cell Lung Cancer and Other Advanced Solid TumorsChristian Kollmannsberger, Herbert Hurwitz, Lyudmila Bazhenova, et al.
Resuscitation|November 20, 2018
Partial pressure of arterial carbon dioxide after resuscitation from cardiac arrest and neurological outcome: A prospective multi-center protocol-directed cohort studyJ Hope Kilgannon, Benton R Hunter, Michael A Puskarich, et al.
Clinical Pharmacology in Drug Development|January 13, 2021
Pharmacokinetics and Safety of PTC596, a Novel Tubulin-Binding Agent, in Subjects With Advanced Solid TumorsGeoffrey I Shapiro, Edward O'Mara, Oscar L Laskin, et al.
Oncogene|April 15, 2008
BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer modelsD Li, L Ambrogio, T Shimamura, et al.
Lung Cancer (Amsterdam, Netherlands)|December 11, 2021
A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancerRuth Plummer, Emma Dean, Hendrik-Tobias Arkenau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2010
A phase I study of foretinib, a multi-targeted inhibitor of c-Met and vascular endothelial growth factor receptor 2Joseph Paul Eder, Geoffrey I Shapiro, Leonard J Appleman, et al.
Pageof 118